Capital Research Global Investors’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.2B | Buy |
20,756,363
+5,008,900
| +32% | +$3.9B | 3.24% | 6 |
|
|
2025
Q1 | $13B | Buy |
15,747,463
+4,989,952
| +46% | +$4.12B | 2.83% | 5 |
|
|
2024
Q4 | $8.3B | Buy |
10,757,511
+1,493,673
| +16% | +$1.15B | 1.71% | 10 |
|
|
2024
Q3 | $8.21B | Buy |
9,263,838
+144,304
| +2% | +$128M | 1.71% | 10 |
|
|
2024
Q2 | $8.26B | Buy |
9,119,534
+1,088,003
| +14% | +$985M | 1.81% | 11 |
|
|
2024
Q1 | $6.25B | Buy |
8,031,531
+453,939
| +6% | +$353M | 1.41% | 11 |
|
|
2023
Q4 | $4.42B | Buy |
7,577,592
+325,342
| +4% | +$190M | 1.09% | 20 |
|
|
2023
Q3 | $3.9B | Buy |
7,252,250
+469,273
| +7% | +$252M | 1.07% | 24 |
|
|
2023
Q2 | $3.18B | Buy |
6,782,977
+654,026
| +11% | +$307M | 0.85% | 27 |
|
|
2023
Q1 | $2.1B | Buy |
6,128,951
+1,037,933
| +20% | +$356M | 0.6% | 44 |
|
|
2022
Q4 | $1.86B | Buy |
5,091,018
+328,249
| +7% | +$120M | 0.56% | 50 |
|
|
2022
Q3 | $1.54B | Buy |
4,762,769
+1,848,662
| +63% | +$598M | 0.51% | 54 |
|
|
2022
Q2 | $945M | Buy |
+2,914,107
| New | +$945M | 0.29% | 80 |
|
|
2013
Q3 | – | Sell |
-800,000
| Closed | -$39.3M | – | 452 |
|
|
2013
Q2 | $39.3M | Buy |
+800,000
| New | +$39.3M | 0.02% | 343 |
|